Pediatric Pharmacotherapy

• Update on Levetiracetam in Infants and Children This article provides an update regarding the use and safety of levetiracetam in the treatment of pediatric epilepsy.
  Pediatric Pharmacotherapy, September 2018
• Fosaprepitant and Aprepitant for CINV in Children Aprepitant and fosaprepitant have been approved for use in pediatric patients for the prevention of chemotherapy-induced nausea and vomiting.
  Pediatric Pharmacotherapy, August 2018
• Use of Acetaminophen for Patent Ductus Arteriosus Closure This article provides an update regarding the use of acetaminophen to close a patent ductus arteriosus.
  Pediatric Pharmacotherapy, July 2018
• News for Pediatric Healthcare Providers From the FDA Which drugs have been newly developed or indicated for pediatric patients? Find out what there is to know.
  Pediatric Pharmacotherapy, June 2018
• A Third Dose of the MMR Vaccine During Mumps Outbreaks Could the administration of a third dose of the MMR vaccine add an additional layer of protection during mumps outbreaks?
  Pediatric Pharmacotherapy, May 2018
• Treatment of Status Epilepticus What are the latest therapeutic options for status epilepticus?
  Pediatric Pharmacotherapy, April 2018
• Drug Fever: Recent Cases From the Medical Literature A review of recent case reports provides insight into the symptoms of drug fever and the agents that have been associated with this condition.
  Pediatric Pharmacotherapy, February 2018
• Extended-Release Methylphenidate Oral Tablets A newly approved extended-release formulation of methylphenidate may be another option for the management of ADHD in children.
  Pediatric Pharmacotherapy, December 2017
• New Drug Approvals and New Pediatric Indications Which drugs are newly indicated for use in pediatric patients? This article provides an update.
  Pediatric Pharmacotherapy, November 2017
• Ceftaroline as an Antibiotic for Pediatric Infections Ceftaroline is an approved antibiotic for the treatment of adult bacterial infections. Could it also be a safe and effective option for children?
  Pediatric Pharmacotherapy, November 2017
• Precision Medicine in Children Review applications in Autoimmunity, Asthma, Infectious Disease, and Many Other Critical Areas
  Pediatric Pharmacotherapy, April 2017
• Hydrocortisone in Managing Bronchopulmonary Dysplasia Is hydrocortisone a safe and effective treatment option for the prevention and treatment of bronchopulmonary dysplasia?
  Pediatric Pharmacotherapy, March 2017
• Budesonide in Children and Adolescents With Crohn's Disease Is budesonide a safe and effective therapeutic option for pediatric Crohn's disease?
  Pediatric Pharmacotherapy, February 2017
• Amphetamine Orally Disintegrating Tablets for ADHD A newly approved extended-release orally disintegrating amphetamine tablet may be another option for the treatment of ADHD.
  Pediatric Pharmacotherapy, January 2017
• Prescription Opioid Misuse by Adolescents How prevalent is the issue of prescription opioid misuse among adolescents -- and what can clinicians do to help prevent this growing problem?
  Pediatric Pharmacotherapy, December 2016
• Barriers to Pediatric Postoperative Pain Management at Home This article provides some guidance regarding the optimal use of analgesics in children who have been discharged home.
  Pediatric Pharmacotherapy, December 2016
• Medication Adherence in Children and Adolescents Which factors may influence whether children and adolescents take their medications as prescribed?
  Pediatric Pharmacotherapy, December 2016
• Ketamine Infusions for Pediatric Sedation and Analgesia Ketamine is commonly used for procedural sedation and analgesia. How safe is it in children?
  Pediatric Pharmacotherapy, December 2016
• Analgesics, Adjunctive Therapy in Pediatric Palliative Care What do we currently know about available medications for improving pain and comfort in the pediatric palliative care setting?
  Pediatric Pharmacotherapy, November 2016
• The Use of N-Acetylcysteine in Acetaminophen Overdose Explore alternative methods for the delivery of N-acetylcysteine to reduce hepatotoxicity in acetaminophen poisoning.
  Pediatric Pharmacotherapy, November 2016